A randomized phase I clinical and biologic study of two schedules of BAY 43-9006 in patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML): A National Cancer Institute of Cancer Clinical Trials Group Study. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Crump, M
  • Leber, Brian
  • Kassis, J
  • Hedley, D
  • Minden, M
  • Buckstein, R
  • McIntosh, L
  • Eisenhauer, E
  • Seymour, L

publication date

  • July 15, 2004